TELA Bio (TELA) Cash from Operations (2018 - 2026)

TELA Bio's Cash from Operations history runs 9 years deep, the most recent figure standing at 11170000.0 for Q1 2026.

• On a quarterly basis, Cash from Operations fell 14.86% year-over-year to 11170000.0 in Q1 2026; TTM through Mar 2026 was 29664000.0, a 19.69% increase from a year earlier, with the FY2025 full-year figure at 28219000.0, up 32.16% from the prior year.
• Cash from Operations eased to 11170000.0 in Q1 2026 per TELA's latest filing, from 4870000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 4870000.0 in Q4 2025 and bottomed at 14384000.0 in Q1 2024.
• The 5-year median for Cash from Operations is 10430000.0 (2022), against an average of 9564058.82.
• Across the five-year window, Cash from Operations sank 107.6% in 2022 and jumped 36.34% in 2025, its largest moves.
• Year by year, Cash from Operations stood at 10983000.0 in 2022, then decreased by 0.62% to 11051000.0 in 2023, then jumped by 31.85% to 7531000.0 in 2024, then surged by 35.33% to 4870000.0 in 2025, then sank by 129.36% to 11170000.0 in 2026.
• Per Business Quant, the three latest TELA Cash from Operations figures stand at 11170000.0 (Q1 2026), 4870000.0 (Q4 2025), and 5719000.0 (Q3 2025).